The angiogenic factor cysteine-rich 61 (CYR61, CCN1) supports vascular smooth muscle cell adhesion and stimulates chemotaxis through integrin α6β1 and cell surface heparan sulfate proteoglycans

被引:162
作者
Grzeszkiewicz, TM
Lindner, V
Chen, NY
Lam, SCT
Lau, LF
机构
[1] Univ Illinois, Dept Mol Genet, Chicago, IL 60607 USA
[2] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA
[3] Maine Med Ctr, Res Inst, Scarborough, ME 04074 USA
关键词
D O I
10.1210/en.143.4.1441
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cysteine-rich 61 (CYR61, CCN1) is a heparin-binding, extracellular, matrix-associated protein of the cysteine-rich 61/nephroblastoma family, which also includes connective tissue growth factor, nephroblastoma overexpressed, Wnt-induced secreted protein-1 (WISP-1), WISP-2, and WISP-3. CYR61 induces angiogenesis in vivo and supports cell adhesion, promotes cell migration, and enhances growth factor-stimulated mitogenesis in fibroblasts and endothelial cells. Although the expression of CYR61 has been observed in arterial walls, its function in vascular smooth muscle cells (VSMCs) has not been examined to date. Here we show that purified CYR61 supports VSMC adhesion in a dose-dependent, saturable manner through integrin alpha(6)beta(1) with an absolute requirement of cell surface heparan sulfate proteoglycans. In addition, CYR61 induces VSMC chemotaxis, but not chemokinesis, through integrin alpha(6)beta(1) and heparan sulfate proteoglycans. Heparin-binding defective CYR61 mutants are unable to support VSMC adhesion but can still induce chemotaxis at a reduced level. Following balloon angioplasty in rat carotid artery, CYR61 protein level is elevated in the media and neointima of the injured vessel by d 4 post angioplasty, peaks from d 7 to 14, and remains high for at least 28 d. These data demonstrate the activities of CYR61 in VSMCs, identify the receptors that mediate its functions, and show that CYR61 is synthesized in arterial smooth muscle walls during proliferative restenosis. Together, these results implicate CYR61 as a novel factor that modulates the responses of VSMCs to vascular injury.
引用
收藏
页码:1441 / 1450
页数:10
相关论文
共 60 条
[1]  
[Anonymous], 1988, Antibodies: A Laboratory Manual
[2]   CYR61, a product of a growth factor-inducible immediate early gene, promotes angiogenesis and tumor growth [J].
Babic, AM ;
Kireeva, ML ;
Kolesnikova, TV ;
Lau, LF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (11) :6355-6360
[3]  
Bartorelli AL, 1997, CATHETER CARDIO DIAG, V42, P313, DOI 10.1002/(SICI)1097-0304(199711)42:3<313::AID-CCD21>3.0.CO
[4]  
2-L
[5]   The biology of restenosis [J].
Bauters, C ;
Isner, JM .
PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 40 (02) :107-116
[6]  
Belkin AM, 2000, MICROSC RES TECHNIQ, V51, P280, DOI 10.1002/1097-0029(20001101)51:3<280::AID-JEMT7>3.0.CO
[7]  
2-O
[8]   Functions of cell surface heparan sulfate proteoglycans [J].
Bernfield, M ;
Götte, M ;
Park, PW ;
Reizes, O ;
Fitzgerald, ML ;
Lincecum, J ;
Zako, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1999, 68 :729-777
[9]   Inhibition of neointimal formation by natural heparan sulfate proteoglycans of the arterial wall [J].
Bingley, JA ;
Campbell, JH ;
Hayward, IP ;
Campbell, GR .
ATHEROSCLEROSIS IV: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE FOURTH SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS, 1997, 811 :238-244
[10]  
BLOOD CH, 1993, CANCER RES, V53, P2661